NuVasive to Release $62.5M from Escrow Following Appeals Court Win

NuVasive, Inc.

, a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today the release of $62.5 million from a restricted escrow account in relation to NuVasive's trademark dispute regarding the NeuroVision(R) trade name.